Armistice Capital »

Ida shares owned by Armistice Capital

Quarter-by-quarter ownership of Ida (IDA) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Ida

Tip: Access up to 7 years of quarterly data

All positions including Ida held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ida by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $204k 1.3k 151.30

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Ida

BlackRock
Vanguard Portfolio Management
Vanguard Capital Management
Wellington Management Company
FMR
Morgan Stanley
State Street Corporation
W. H. Reaves & Co
Pictet Asset Management Holding SA
Two Sigma Investments
Geode Capital Management
Jennison Associates
Capital World Investors
Alliancebernstein
Citadel Advisors

View all funds holding Ida